Company: LHI
Filing Date: 2025-08-08
Form Type: F-1/A
Source: 0001213900-25-073646
Chunk: 48

Company: Living Homeopathy International Ltd.
Filing Date: 2025-08-08
Form: F-1/A
Chunk 48
---
 Shares and 520,000 Class
B Ordinary Shares, representing approximately 52% of our total voting power of our outstanding
Ordinary Shares, and Qingtian Holdings Ltd., the other Class B shareholder, holds 2,820,000
Class A Ordinary Shares and 480,000 Class B Ordinary Shares, representing approximately 41.75%
of our total voting power. See “Principal Shareholder” on page 100 of
this prospectus for details. Immediately after the completion of the offering, our directors
and officers and Class B shareholders will collectively control an aggregate of 91.09% of
the total voting power of our outstanding Ordinary Shares, and Mr. To will be beneficially
interested in an aggregate of 49.43 % of the total voting power of our outstanding Ordinary
Shares. Immediately after the completion of this offering, assuming the underwriters do not
exercise their over-allotment option, our Class B shareholders, consisting of LTO Holdings
Ltd., wholly owned by Mr. To, and Qingtian Holdings Ltd. will own an aggregate of 89.11%
of our total voting power of our outstanding Ordinary Shares. Assuming the two Class B shareholders
continue to hold 7,500,000 Class A Ordinary Shares and 1,000,000 Class B Ordinary Shares,
so long as the total ordinary shares hold by the two Class B shareholders represent more
than 26.7% of our total outstanding ordinary shares, the two Class B shareholders, if vote
together, will continue to control the outcome of matters submitted to shareholders for approval.
In cases where their interests are aligned and they vote together, our directors and officers
who are beneficial owners and the Class B Shareholders could have significant influence on
determining the outcome of any corporate transaction or other matter submitted to the shareholders
for approval, including mergers, consolidations, the election of directors and other significant
corporate actions. In cases where their interests are aligned and they vote together, they
will also have the power to prevent or cause a change in control. Without the consent of
some or all of these shareholders, we may be prevented from entering into transactions
that could be beneficial to us or our minority shareholders. The interests of these
beneficial owners may differ from the interests of our other shareholders. The concentration
in the ownership of our Ordinary Shares may cause a material decline in the value of our
Class A Ordinary Shares. For more information regarding our beneficial owners and their affiliated